• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越无呼吸机天数:几种估计量的综述

Beyond the ventilator-free days: review of several estimands.

作者信息

Renard Triché Laurent, Jabaudon Matthieu, Chevret Sylvie

机构信息

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 rue Montalembert, Clermont-Ferrand, 63 000, France.

iGReD, INSERM, CNRS, Université Clermont Auvergne, Clermont-Ferrand, France.

出版信息

Crit Care. 2025 Aug 4;29(1):343. doi: 10.1186/s13054-025-05593-3.

DOI:10.1186/s13054-025-05593-3
PMID:40760700
Abstract

BACKGROUND

Mortality is a critical endpoint in clinical research, but identifying meaningful differences necessitates large sample sizes. Consequently, composite outcomes such as ventilator-free days (VFDs) have been developed, combining survival and ventilation duration into a single measure. Different statistical methods used to analyse VFDs lead to different estimands. Traditionally, VFDs are treated as a count; however, some models consider time to death and time to extubation separately. This review explores the applicability of several time-to-event models and innovative approaches.

MAIN TEXT

The first model to consider is the competing risks approach using the Fine-Gray model. This approach focuses solely on the initial extubation event and considers death as a competing event. Second, to incorporate all extubation and reintubation events, multistate models can be employed. Specifically, the multiple-event framework, which allows for multiple transitions between intubation and extubation, while the recurrent events framework, focuses on extubation recurrence. However, these models require complete data and a sufficient number of events for analysis. Third, current ventilation-free survival estimates use methods adapted from leukaemia-free survival to evaluate the probability of remaining extubated and alive over time. Finally, the mixture cure model distinguishes between deceased and extubated individuals within the non-deceased population. It models death through logistic regression and extubation timing through survival regression among living patients.

CONCLUSION

In critical care, especially for acute respiratory distress syndrome, three key states are intubation, extubation, and death. We do not advocate a one-size-fits-all model because the choice depends heavily on the specific goals. The key is to decide which estimand the study will target in the statistical plan, before initiating the study, and to ensure the analysis model is the most appropriate for addressing the research question. .

摘要

背景

死亡率是临床研究中的关键终点,但要识别有意义的差异需要大样本量。因此,诸如无呼吸机天数(VFDs)等复合结局被开发出来,将生存和通气持续时间合并为一个单一指标。用于分析VFDs的不同统计方法会导致不同的估计量。传统上,VFDs被视为一个计数指标;然而,一些模型分别考虑死亡时间和拔管时间。本综述探讨了几种生存时间模型和创新方法的适用性。

正文

首先要考虑的模型是使用Fine-Gray模型的竞争风险方法。这种方法仅关注初始拔管事件,并将死亡视为竞争事件。其次,为了纳入所有拔管和重新插管事件,可以采用多状态模型。具体来说,多事件框架允许在插管和拔管之间进行多次转换,而复发事件框架则关注拔管复发。然而,这些模型需要完整的数据和足够数量的事件用于分析。第三,当前的无通气生存估计使用从无白血病生存改编而来的方法来评估随时间保持拔管和存活的概率。最后,混合治愈模型区分未死亡人群中的死亡个体和拔管个体。它通过逻辑回归对死亡进行建模,并通过生存回归对存活患者的拔管时间进行建模。

结论

在重症监护中,特别是对于急性呼吸窘迫综合征,三个关键状态是插管、拔管和死亡。我们不主张采用一刀切的模型,因为选择很大程度上取决于具体目标。关键是在研究开始前在统计计划中确定研究将针对的估计量,并确保分析模型最适合解决研究问题。

相似文献

1
Beyond the ventilator-free days: review of several estimands.超越无呼吸机天数:几种估计量的综述
Crit Care. 2025 Aug 4;29(1):343. doi: 10.1186/s13054-025-05593-3.
2
Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.拔管后早产儿使用鼻间歇正压通气(NIPPV)与鼻持续气道正压通气(NCPAP)的比较
Cochrane Database Syst Rev. 2017 Feb 1;2(2):CD003212. doi: 10.1002/14651858.CD003212.pub3.
3
Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.经鼻间歇正压通气(NIPPV)与经鼻持续气道正压通气(NCPAP)用于早产儿拔管后
Cochrane Database Syst Rev. 2014 Sep 4(9):CD003212. doi: 10.1002/14651858.CD003212.pub2.
4
Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation.用于机械通气的危重症患者拔管或撤机的咳嗽增强技术。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD011833. doi: 10.1002/14651858.CD011833.pub2.
5
Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants.拔管后即刻经鼻持续气道正压通气预防早产儿发病率。
Cochrane Database Syst Rev. 2024 Oct 11;10(10):CD000143. doi: 10.1002/14651858.CD000143.pub2.
6
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.影响重症成人和儿童机械通气撤机方案使用的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2.
7
Short-Term Memory Impairment短期记忆障碍
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
Systemic corticosteroids for the treatment of COVID-19.全身性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.

本文引用的文献

1
What is the optimal approach to analyse ventilator-free days? A simulation study.分析无呼吸机天数的最佳方法是什么?一项模拟研究。
Crit Care. 2025 Jun 19;29(1):251. doi: 10.1186/s13054-025-05474-9.
2
Alternative approaches to analyzing ventilator-free days, mortality and duration of ventilation in critical care research.重症监护研究中分析无呼吸机天数、死亡率和通气持续时间的替代方法。
Crit Care Sci. 2024 May 24;36:e20240246en. doi: 10.62675/2965-2774.20240246-en. eCollection 2024.
3
The estimands framework: a primer on the ICH E9(R1) addendum.
估计量框架:ICH E9(R1)增编入门指南。
BMJ. 2024 Jan 23;384:e076316. doi: 10.1136/bmj-2023-076316.
4
Sample size estimation in clinical trials using ventilator-free days as the primary outcome: a systematic review.临床试验中以呼吸机使用天数为主要结局指标的样本量估计:系统综述。
Crit Care. 2023 Aug 1;27(1):303. doi: 10.1186/s13054-023-04562-y.
5
Defining estimands in clinical trials: A unified procedure.定义临床试验中的估计量:一种统一方法。
Stat Med. 2023 May 30;42(12):1869-1887. doi: 10.1002/sim.9702. Epub 2023 Mar 8.
6
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes.赢率(赢率比、赢率优势和净效益)可以相互补充,以显示对生存时间结局的治疗效果的强度。
Pharm Stat. 2023 Jan;22(1):20-33. doi: 10.1002/pst.2251. Epub 2022 Jun 27.
7
Harmonizing Heterogeneous Endpoints in Coronavirus Disease 2019 Trials Without Loss of Information.协调新冠肺炎临床试验中无信息损失的异质终点。
Crit Care Med. 2021 Jan 1;49(1):e11-e19. doi: 10.1097/CCM.0000000000004741.
8
Alive and Ventilator Free: A Hierarchical, Composite Outcome for Clinical Trials in the Acute Respiratory Distress Syndrome.存活且无需呼吸机:急性呼吸窘迫综合征临床试验的分层综合结局。
Crit Care Med. 2020 Feb;48(2):158-166. doi: 10.1097/CCM.0000000000004104.
9
Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial.法国急性呼吸窘迫综合征患者肺形态个体化机械通气与低呼气末正压通气的比较(LIVE 研究):一项多中心、单盲、随机对照试验。
Lancet Respir Med. 2019 Oct;7(10):870-880. doi: 10.1016/S2213-2600(19)30138-9. Epub 2019 Aug 6.
10
Reappraisal of Ventilator-Free Days in Critical Care Research.重新评估重症监护研究中的无呼吸机天数。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836. doi: 10.1164/rccm.201810-2050CP.